Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2C19 Polymorphism Effect on H. pylori Eradication
NCT03650543Phase 4Completed
- Sponsor
- Pontificia Universidad Javeriana
- Start
- Sep 2012
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, single-blind trial of omeprazole in Helicobacter pylori infection (2 arms), sponsored by Pontificia Universidad Javeriana. Primary endpoint: Effectiveness of each therapy by protocol (PP). Started Sep 2012; status: completed.
02
Drugs
omeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03650543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03650543.